Notes from 2017, hopes for 2018.
出版信息
Nat Rev Clin Oncol. 2018 Jan 22;15(2):63. doi: 10.1038/nrclinonc.2018.4.
PMID:29359736
Abstract
摘要
相似文献
1
Notes from 2017, hopes for 2018.2017年的记录，2018年的期望。
Nat Rev Clin Oncol. 2018 Jan 22;15(2):63. doi: 10.1038/nrclinonc.2018.4.
2
Approvals in 2017: gene therapies and site-agnostic indications.2017年的获批情况：基因疗法与不限癌种适应症
Nat Rev Clin Oncol. 2018 Mar;15(3):127-128. doi: 10.1038/nrclinonc.2018.11. Epub 2018 Jan 31.
3
Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers.免疫疗法：替沙格赛定 - 首个获批的嵌合抗原受体T细胞疗法：对支付方和政策制定者的影响
Nat Rev Clin Oncol. 2018 Jan;15(1):11-12. doi: 10.1038/nrclinonc.2017.156. Epub 2017 Oct 4.
4
Acute lymphoblastic leukaemia in 2017: Immunotherapy for ALL takes the world by storm.2017年的急性淋巴细胞白血病：急性淋巴细胞白血病的免疫疗法席卷全球。
Nat Rev Clin Oncol. 2018 Feb;15(2):69-70. doi: 10.1038/nrclinonc.2017.176. Epub 2017 Dec 19.
5
CAR-T Therapy Is Approved for Mantle Cell Lymphoma.嵌合抗原受体T细胞（CAR-T）疗法获批用于套细胞淋巴瘤。
JAMA. 2020 Sep 1;324(9):832. doi: 10.1001/jama.2020.15456.
6
CAR T cells - what have we learnt?嵌合抗原受体T细胞——我们学到了什么？
Nat Rev Clin Oncol. 2017 Dec 15;15(1):1. doi: 10.1038/nrclinonc.2017.196.
7
EEG findings in CAR T-cell therapy-related encephalopathy.嵌合抗原受体T细胞疗法相关脑病的脑电图检查结果
Neurology. 2018 Jul 31;91(5):227-229. doi: 10.1212/WNL.0000000000005910. Epub 2018 Jun 29.
8
Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.嵌合抗原受体修饰 T 细胞疗法的临床前模型。
Hum Gene Ther. 2018 May;29(5):534-546. doi: 10.1089/hum.2017.243. Epub 2018 Mar 14.
9
Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art.用于泌尿生殖系统恶性肿瘤的新一代T细胞疗法，A部分：引言与当前技术水平
Cancer Treat Res Commun. 2018;17:8-12. doi: 10.1016/j.ctarc.2018.08.001. Epub 2018 Aug 22.
10
An Interview with Michel Sadelain, MD, PhD.医学博士、哲学博士米歇尔·萨德莱恩访谈
Hum Gene Ther. 2018 May;29(5):530-533. doi: 10.1089/hum.2018.29063.msa.
Zotero 插件